Global research issues take center stage in this week’s Research Ethics Roundup. Recently, the Chinese government announced new draft regulations on lab animal welfare. The results of the Ebola trials are being analyzed and French officials are launching an investigation after a fatal clinical trial.
Ebola's Thin Harvest: In this special report for Science, Jon Cohen and Martin Enserink report on the results of the Ebola clinical trials. They point out, "Never before had the disease affected enough people to allow researchers to test Ebola drugs and vaccines in a real-world setting." Unfortunately, the findings from many of these trials are unclear.
This piece, which originally appeared on Speaking of Research, has been reposted with permission.
[On December 11], Buzzfeed broke a story reporting on the planned phase-out of on-site housing of monkeys at one of the National Institutes of Health intramural laboratories, the National Institute of Child Health and Human Development (NICHD) Laboratory of Comparative Ethology in Poolesville, Maryland. As NICHD Director Constantine Stratakis outlined in an interview with Science News, the phase-out has been in the [...] Read more
From the progress in gene therapy for genetic retinal diseases to a survey that finds the majority of animal studies for drugs are not rigorous enough, this week’s Research Ethics Roundup examines some of the latest controversial issues occurring in research ethics.
23andMe Will Resume Giving Users Health [...] Read more
From a study that explores the regulatory burden researchers face to the development of a device that applies a biodegradable adhesive to internal organs, this week's Research Ethics Roundup delves into how advances in technology and changes in regulations are impacting the course of research.
From a new report that indicates that the use of regulated animals in biomedical research is declining to an editorial arguing for the use of female mice in research, animal research takes center stage in this week’s Research Ethics Roundup.
Conflicts of Interest on Institutional Review Boards Remain Problematic: A recent study in JAMA Internal Medicine concluded that while there has been significant progress with respect to reporting and managing institutional review board (IRB) member conflict of interests, there is still more work to be done. Ed Silverman reports on the findings in this article from The Wall Street Journal’s Pharmalot[...] Read more